Market Overview The human lyophilized rabies vaccine market is elevating as post-exposure prophylaxis access expands across endemic regions. The Human Lyophilized Rabies Vaccine Market is projected to grow through 2030, driven by animal bite exposure management need, pre-exposure prophylaxis demand, cold-chain-independent stability preference, and global rabies elimination program support...